A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth
{{output}}
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer that lacks reliable targets for diagnosis and therapy. Non-coding RNA (ncRNA)-encoded products hold promise for addressing this unmet need. By analyzing the reported ribosomal ... ...
